Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 6, 2008, Pages 2955-2967

  Rönn, Robert ^a   Lampa, Anna ^a   Peterson, Shane D ^a   Gossas, Thomas ^b   Åkerblom, Eva ^a   Danielson, U Helena ^b   Karlén, Anders ^a   Sandström, Anja ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acyl sulfonamide; Carbonylation; HCV; NS3; Palladium; Protease inhibitor

Indexed keywords

AMINOBENZOYL SULFONAMIDE; NONSTRUCTURAL PROTEIN 3 PROTEASE INHIBITOR; PALLADIUM; PROTEINASE INHIBITOR; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CARBONYLATION; CATALYSIS; DRUG DETERMINATION; DRUG INHIBITION; DRUG SYNTHESIS; MICROWAVE IRRADIATION;

MICROWAVES; PALLADIUM; SERINE PROTEINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 40949140556     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.12.041     Document Type: Article

References (43)

1. Shepard C.W., Finelli L., and Alter M.J. Lancet Infect. Dis. 5 (2005) 558-567
2. Pearlman B.L. Am. J. Med. 117 (2004) 344-352
3. Appel N., Schaller T., Penin F., and Bartenschlager R. J. Biol. Chem. 281 (2006) 9833-9836
4. Bartenschlager R., and Lohmann V. J. Gen. Virol. 81 (2000) 1631-1648
5. Gale M., and Foy E.M. Nature 436 (2005) 939-945
6. Steinkühler C., Biasiol G., Brunetti M., Urbani A., Koch U., Cortese R., Pessi A., and De Francesco R. Biochemistry 37 (1998) 8899-8905
7. Llinàs-Brunet M., Bailey M., Fazal G., Goulet S., Halmos T., Laplante S., Maurice R., Poirier M., Poupart M.-A., Thibeault D., Wernic D., and Lamarre D. Bioorg. Med. Chem. Lett. 8 (1998) 1713-1718
8. Steinkühler C., Koch U., Narjes F., and Matassa V.G. Curr. Med Chem. 8 (2001) 919-932
9. McPhee F., Yeung K.-S., Good A.C., and Meanwell N.A. Drugs of the Future 28 (2003) 465-488
10. Goudreau N., and Llinàs-Brunet M. Expert Opin. Investig. Drugs 14 (2005) 1129-1144
11. Thomson J.A., and Perni R.B. Curr. Opin. Drug Discov. Dev. 9 (2006) 606-617
12. Lamarre D., Anderson P.C., Bailey M., Beaulieu P., Bolger G., Bonneau P., Boes M., Cameron D.R., Cartier M., Cordingley M.G., Faucher A.-M., Goudreau N., Kawai S.H., Kukolj G., Lagace L., LaPlante S.R., Narjes H., Poupart M.-A., Rancourt J., Sentjens R.E., St George R., Simoneau B., Steinmann G., Thibeault D., Tsantrizos Y.S., Weldon S.M., Yong C.-L., and Llinàs-Brunet M. Nature 426 (2003) 186-189
13. Press release at the Vertex homepage: http://www.vrtx.com/Pressreleases2006/pr121306.html (accessed Feb 2007).
14. Press release at the Schering-Plough homepage: http://www.schering-plough.com/schering_plough/news/release. jsp?releaseID=845117 (accessed Feb 2007).
15. Hinrichsen H., Benhamou Y., Wedemeyer H., Reiser M., Sentjens R.E., Calleja J.L., Forns X., Erhardt A., Croenlein J., Chaves R.L., Yong C.-L., Nehmiz G., and Steinmann G.G. Gastroenterology 127 (2004) 1347-1355
16. Press release at the InterMune homepage: http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=ITMN&script=410&layout=6&item_id=943483&sstring=itmn-191 (accessed Feb 2007).
17. Chen S.-H., Lamar J., Yip Y., Victor F., Johnson R.B., Wang Q.M., Glass J.I., Heinz B., Colacino J., Guo D., Tebbe M., and Munroe J.E. Letters in Drug Design & Discovery 2 (2005) 118-123
18. Malcolm B.A., Liu R., Lahser F., Agrawal S., Belanger B., Butkiewicz N., Chase R., Gheyas F., Hart A., Hesk D., Ingravallo P., Jiang C., Kong R., Lu J., Pichardo J., Prongay A., Skelton A., Tong X., Venkatraman S., Xia E., Girijavallabhan V., and Njoroge F.G. Antimicrob. Agents Chemother. 50 (2006) 1013-1020
19. Seiwert, S.; Andrews, S.W.; Yang, H.; Tan, H.; Marafino, B.; Rieger, R.; Franklin, R.B.; Pheneger, J.; Lee, P.A.; Jiang, Y.; Kennedy, A.L.; Wenglowsky, S.M.; Madduru, M.R.; Doherty, G.A.; Condroski, K.R.; Lemieux, C.; Pieti Opie, L.; Sullivan, F.; Neitzel, N.; Hingorani, G.P.; Otten, J.; Brandhuber, B.; Vigers, G.; Josey, J.A.; Blatt, L.M. Preclinical Characteristics of ITMN 191, an Orally Active Inhibitor of the HCV NS3/4A Protease Nominated for Preclinical Development. Digestive Disease Week, May 20-25, Los Angeles 2006, Poster #T1793.
20. Condroski, K.R.; Zhang, H.; Seiwert, S.D.; Ballard, J.A.; Bernat, B.A.; Brandhuber, B.J.; Andrews, S.W.; Josey, J.A.; Blatt, L.M. Structure-Based Design of Novel Isoindoline Inhibitors of HCV NS3/4A Protease and Binding Mode Analysis of ITMN-191 by X-ray Crystallography. Digestive Disease Week, May 20-25, Los Angeles 2006, Poster #T1794.
21. Lin C., Lin K., Luong Y.-P., Rao B.G., Wei Y.-Y., Brennan D.L., Fulghum J.R., Hsiao H.-M., Ma S., Maxwell J.P., Cottrell K.M., Perni R.B., Gates C.A., and Kwong A.D. J. Biol. Chem. 279 (2004) 17508-17514
22. Lin C., Gates C.A., Rao B.G., Brennan D.L., Fulghum J.R., Luong Y.-P., Frantz J.D., Lin K., Ma S., Wei Y.-Y., Perni R.B., and Kwong A.D. J. Biol. Chem. 280 (2005) 36784-36791
23. Tong X., Chase R., Skelton A., Chen T., Wright-Minogue J., and Malcolm B.A. Antiviral Res. 70 (2006) 28-38
24. Reesink H.W., Zeuzem S., Weegink C.J., Forestier N., Van Vliet A., Van De Wetering De Rooij J., McNair L., Purdy S., Kauffman R., Alam J., and Jansen P.L.M. Gastroenterology 131 (2006) 997-1002
25. Veber D.F., and Freidinger R.M. Trends Neurosci. 8 (1985) 392-396
26. Campbell, J.A.; Good, A. Preparation of tripeptides as hepatitis C inhibitors. WO 02/060926, 2002.
27. Rijkers D.T.S., Adams H.P.H.M., Hemker H.C., and Tesser G.I. Tetrahedron 51 (1995) 11235-11250
28. Wu X., Rönn R., Gossas T., and Larhed M. J. Org. Chem. 70 (2005) 3094-3098
29. Herrmann W.A., Brossmer C., Reisinger C.-P., Riermeier T.H., Ofele K., and Beller M. Chem. Eur. J. 3 (1997) 1357-1364
30. Netherton M.R., and Fu G.C. Org. Lett. 3 (2001) 4295-4298
31. Kaiser N.-F.K., Hallberg A., and Larhed M. J. Comb. Chem. 4 (2002) 109-111
32. Poliakov A., Hubatsch I., Shuman C.F., Stenberg G., and Danielson U.H. Protein Expr. Purif. 25 (2002) 363-371
33. Lohmann V., Korner F., Koch J.O., Herian U., Theilmann L., and Bartenschlager R. Science 285 (1999) 110-113
34. Tsantrizos Y.S., Bolger G., Bonneau P., Cameron D.R., Goudreau N., Kukolj G., LaPlante S.R., Llinàs-Brunet M., Nar H., and Lamarre D. Angew. Chem., Int. Ed. 42 (2003) 1356-1360
35. Johansson A., Poliakov A., Åkerblom E., Wiklund K., Lindeberg G., Winiwarter S., Danielson U.H., Samuelsson B., and Hallberg A. Bioorg. Med. Chem. 11 (2003) 2551-2568
36. Rönn R., Sabnis Y.A., Gossas T., Åkerblom E., Danielson U.H., Hallberg A., and Johansson A. Bioorg. Med. Chem. 14 (2006) 544-559
37. Örtqvist P., Peterson S.D., Åkerblom E., Gossas T., Sabnis Y.A., Fransson R., Lindeberg G., Danielson U.H., Karlén A., and Sandström A. Bioorg. Med. Chem. 15 (2007) 1448-1474
38. Yao N., Reichert P., Taremi S.S., Prosise W.W., and Weber P.C. Structure 7 (1999) 1353-1363
39. Rönn R., Gossas T., Sabnis Y.A., Daoud H., Åkerblom E., Danielson U.H., and Sandström A. Bioorg. Med. Chem. 15 (2007) 4057-4068
40. Katayama S., Ae N., Kodo T., Masumoto S., Hourai S., Tamamura C., Tanaka H., and Nagata R. J. Med. Chem. 46 (2003) 691-701
41. Johansson A., Poliakov A., Åkerblom E., Lindeberg G., Winiwarter S., Samuelsson B., Danielson U.H., and Hallberg A. Bioorg. Med. Chem. 10 (2002) 3915-3922
42. McMartin C., and Bohacek R.S. J. Comput. -Aided Mol. Des. 11 (1997) 333-344
43. Teague S.J. Nat. Rev. Drug Discov. 2 (2003) 527-541